Company Symposia


Sunday, 25.9.2005

*Acri.Tec GmbH (München, Hennigsdorf/D)
12.30 - 13.30 hrs
ICC, Room 42
Lunch Symposium: Clinical Experiences with Innovative Acrylic IOL: PCO Development, Optimization of Visual Acuity, Correction of Presbyopia
information

Sunday, 25.9.2005

AMO Germany GmbH (Ettlingen/D)
14.30 – 15.30 hrs
ICC, Hall 7
Satellite Symposium: Wavefront Optimization and Guidance in Cataract and Refractive Surgery
information

Monday, 26.9.2005

Alcon Laboratories, Inc. (Fort Worth/USA)

13.00 – 14.00 hrs
ICC, Hall 9

Lunch Symposium: Therapy and Prophylaxis of Age-related Macular Degeneration (AMD) – A Situational Analysis
information

Monday, 26.9.2005

Wavelight Laser Technologie AG (Erlangen/D)
16.00 – 17.00 hrs
ICC, Room Madrid
Satellite Symposium: Case studies and treatment strategies in refractive laser surgery
information

Monday, 26.9.2005

Pharm-Allergan GmbH (Ettlingen/D)

16.30 – 18.00 hrs
ICC, Hall 4/5

Symposium: Risk of Glaucoma Progression
information

Tuesday, 27.9.2005

Chibret GmbH (Haar/D)
09.00 - 10.00 hrs
Messe, Hall 14.2 (Oslo)
Satellite Symposium: Preservatives in Glaucoma Therapy
information

Tuesday, 27.9.2005

Novartis Pharma AG (Basel/CH)
10.30 - 12.00 hrs
ICC, Hall 4/5
Satellite Symposium: Verteporfin in Combination with Triamcinolone in the Management of Neovascular AMD 
information

Tuesday, 27.9.2005

Bausch & Lomb / Dr. Mann Pharma (Berlin/D)
13.00 - 14.00 hrs
Messe, Hall 14.2 (Oslo)
Lunch Symposium: Study Report – Macular Pigment: Changes under Ocuvite Lutein Supplementation
information

Tuesday, 27.9.2005

Optos GmbH (Munich/D)
16.30 - 17.30 hrs
ICC, Room Hongkong
Satellite Symposium: New Technology in 200° Ultra Widefield Retinal Imaging 
information

Wednesday, 28.9.2005

Alcon Laboratories, Inc. (Fort Worth/USA)

13.00 – 14.00 hrs
ICC, Hall 4/5

Lunch Symposium: A Brief Update on Glaucoma – From Pathogenesis to Therapy
information

Wednesday, 28.9.2005

Pfizer GmbH (Karlsruhe/D)

13.00 – 14.00 hrs
Messe, Hall 14.2 (Oslo) 

Lunch Symposium: Meeting Patient Demands for a Targeted Solution to Dry Eye
information